Skip to main content

Value Stock - Dividend - Research Selection


Market price date:
Market price:  

Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Key figures
Cash flow
Balance sheet
Income statement
Div. Yield%

Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.

Market Capitalization USD
Raw Data Source
Stock Split

Description of the company

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources::,,


Ally Financial: I Can't Find A Reason Not To Buy

Ally Financial has been heading down as a reaction to auto loan exposure. Read why I am increasingly Bullish on ALLY's long-term prospects.

Buy 4 November Buffett Dividend Dogs And Watch 4 More

This Buffett/Berkshire batch of dividend stocks is perfect for the dogcatcher process. Click here for a full breakdown and analysis.

3 Top Dividend Stocks to Buy Now With Yields of 3.4% or More

Right now all three of these top dividend stocks offer yields above the 3% threshold that many investors consider acceptable. AbbVie (NYSE: ABBV) is the biopharmaceutical company behind Humira, a top-selling drug for arthritis and psoriasis. The stock offers an above-average yield of 3.8% right now because Humira won't be on the list of top sellers for much longer.

Now May Be The Time To Invest In Ally Financial

Ally Financial offers financing options to consumers and corporates. Read more to see why I think ALLY could be an interesting risk-reward play.

Warren Buffett’s Stock Portfolio and 10 Newest Investments in 2022

In this article, we discuss Warren Buffett’s 10 newest investments in 2022. If you want to see more stocks in this selection, check out Warren Buffett’s Stock Portfolio and 5 Newest Investments in 2022. Warren Buffett’s Berkshire Hathaway acquiring a $4.1 billion stake in chipmaker Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM) during the third quarter […]

3 High-Dividend Bank Stocks With Yields Above 4%

The surge of inflation this year has put numerous companies under pressure -- but banks are a bright spot. Here are three offering attractive yields.

Carvana Holders Gird for Worst With Credit Risk, Losses Mounting

(Bloomberg) -- It took Carvana Co. just a few years to grow from a startup to the second-biggest used car seller in the US. Most Read from BloombergMusk’s ‘Hardcore’ Ultimatum Sparks Exodus, Leaving Twitter at RiskFTX’s New Boss Reveals Chaos Left Behind by Bankman-FriedGOP Retakes US House by Slim Margin in Washington Power ShiftXi Looks Away From Putin Toward West in World Stage ReturnThis Is the Memo Twitter Sent Telling Staff Offices Were ClosedIts downfall may be even faster.The company bur

Why Is Ally Financial (ALLY) Down 0.2% Since Last Earnings Report?

Ally Financial (ALLY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Ally Financial exec Diane Morais named Queens University's 2022 Business Woman of the Year

Queens University of Charlotte has revealed its next local leader to receive its 38th annual BusinessWoman of the Year award.

7 Warren Buffett Stocks With Room to Run in 2023

When Berkshire Hathaway (NYSE:BRK-B) posted operating earnings growth of 20%, this reaffirmed how well Warren Buffett and its team manage the conglomerate. The company benefited from impressive net income from its insurance investment, as sell as surging profits from its utility and energy holdings. With these strong operating earnings, Berkshire has been able to improve shareholder returns by buying back over $1 billion of its common stock. For investors looking to create a wealth-creation mach